Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biologics
Biotech
Big pharma cuts and gene therapy woes: Inside Q3's layoffs
If the layoff rate remains constant, one could expect 252 workforce reductions by the end of the year—a 27% percentage point jump from 2024.
Gabrielle Masson
Oct 3, 2025 4:30pm
Rocket aborts mission to get rare disease gene therapy approved
Oct 3, 2025 9:30am
Takeda lays off 137 US staff as part of cell therapy retreat
Oct 1, 2025 3:13pm
Novo calls off $598M Heartseed collab, citing 'strategic reviews'
Sep 30, 2025 1:55pm
Opus sets sights on FDA talks after posting gene therapy data
Sep 30, 2025 9:15am
Biogen discontinues all AAV gene therapy work
Sep 26, 2025 11:04am